.png){kind=icon}
Return
Ketamine
.png){kind=icon}
PRE
AI
DOI：10.1016/j.jpainsymman.2015.06.002.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
The use of ketamine is associated with neuropsychiatric, urinary tract and hepatobiliary toxicity. Although most reports involve long-term recreational abusers, it has also arisen after only 1-2 weeks of therapeutic use (Box A). Accordingly, the use of ketamine should be restricted to specialists in pain or palliative care for patients who have failed to obtain relief from standard drug and non-drug treatments.
Keywords:
DOSE INTRAMUSCULAR KETAMINE
REFRACTORY CANCER PAIN
COMMON BILE-DUCTS
ORAL S-KETAMINE
DOUBLE-BLIND
INTRAVENOUS KETAMINE
SUBCUTANEOUS KETAMINE
BURST KETAMINE
EMERGENCY-DEPARTMENT
CLINICAL-EXPERIENCE
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
IF:
3.5
Papers:
9.8K
Citations:
1.5W
Organization
Cited Papers
Alternative treatments of breakthrough pain in patients receiving spinal analgesics for cancer pain
OAAI
OAAIShareSaveOutpatient intravenous ketamine for the treatment of complex regional pain syndrome: A double-blind placebo controlled study.png)
PAIN
PAINIF5.5
PREAI
ShareSaveThe prevalence and natural history of urinary symptoms among recreational ketamine usersBJU INTERNATIONALOAAI
BJU INTERNATIONALIF4.4
OAAIShareSaveShareSaveShareSave
View more